[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

20012,529 citationsJournal Article

Authors

Hans‐Henrik Parving · Steno Diabetes Center

Hendrik Lehnert · University Hospital Magdeburg

Jens Brøchner‐Mortensen · Aalborg University Hospital

Ramón Gomis · Universitat de Barcelona

Steen Andersen · Steno Diabetes Center

Peter Arner · Integrated Cardio Metabolic Centre

Abstract

Irbesartan is renoprotective independently of its blood pressure lowering effect in type 2 diabetic subjects with microalbuminuria. It is safe and well tolerated.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Pharmacology and Obesity Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 163, Issue 40, pp. 5519-24

Field-Weighted Citation Impact: 112.31